InsidersTradesSigma
Follow the 에이프로젠 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Industrials sector, 에이프로젠 has logged 153 insider filings. Market capitalisation: €56.8bn. The latest transaction was disclosed on 16 July 2026 (Purchase). Among the most active insiders: 지베이스. The full history is free.
147
Insider Decl.
n/a
Thresholds
€1m
22 ops.
Buy Volume
€3m
68 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,549 of 29,055 companies
9.1
score / 100
Value1
Quality18
FCF yld-142%
Earn yld-154%
EV/EBITDA·
ROE-30%
Gross mgn28%
Net mgn-60%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations153 total
Other
Other
Other
Other
Other
Other
25 of 153 declarations
关于 에이프로젠
Aprogen 是一家在工业领域运营的公司，在 XKRX 上市。它专注于生物制药产品的开发和生产。